Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that Humana, a major U.S. health insurer, has updated its coverage policy to include adolescents aged 15-21 in response to …
Humana Pioneers Coverage Expansion for Adolescent Depression Treatment Following FDA Clearance Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. This collaboration marks a critical step …
Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial Read More
CHESTERBROOK, PA — Trevena Inc. (Nasdaq: TRVN), a biopharmaceutical company, spotlighted its first-quarter achievements and financial standing, underscoring advancements in its novel treatment for chronic pain and epilepsy and strategic …
Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on innovative therapies, announced the completion of dosing in the second cohort of its groundbreaking GARDian clinical trial for …
Ocugen Advances with Phase 1/2 Trial for Stargardt Disease Treatment Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on gene therapies for eye diseases, reported its first-quarter financial results for 2024 and provided an update on its …
Ocugen Advances Gene Therapy Trials, Targets 2026 for Key Regulatory Approvals Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced a series of achievements and financial milestones for the first quarter ending March 31, 2024. The company’s strides in …
Verrica Pharmaceuticals Reports Growth and Innovation in First Quarter Financial Results Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company, has released its financial outcomes for the first quarter ending March 31, 2024, and concurrently provided insights into …
Galera Therapeutics Explores Strategic Options Amid Financial Results Announcement Read More
MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP), a leading firm in digital payment solutions, announced noteworthy growth in its third quarter results for the fiscal year ending March 31, 2024. …
Cantaloupe, Inc. Posts Strong Third Quarter Results Amid Global Expansion Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY), a leading global provider of comprehensive software solutions for advancing infrastructure, disclosed an encouraging start to 2024, reflecting continued growth and increased …
Bentley Systems Reports Strong Start in 2024, Announces CEO Transition Amid Digital Transformation Focus Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) recently revealed a novel approach to shareholder incentives by declaring a dividend of Series C Preferred Stock. For every share of common stock …
Ocugen Announces Unique Dividend Strategy with Series C Preferred Stock Read More